In a previous report, the cDNA for human proteinase inhibitor 8 (PI8)
was first identified, isolated, and subcloned into a mammalian express
ion vector and expressed in baby hamster kidney cells, Initial studies
indicated that PI8 was able to inhibit the amidolytic activity of try
psin and form an SDS-stable similar to 67-kDa complex with human throm
bin [Sprecher, C. A., et al. (1995) J. Biol Chem. 270, 29854-29861], I
n the present study, we have expressed recombinant PI8 in the methylot
ropic yeast Pichia pastoris, purified the inhibitor to homogeneity, an
d investigated its ability to inhibit a variety of proteinases. PI8 in
hibited the amidolytic activities of porcine trypsin, human thrombin,
human coagulation factor Xa, and the Bacillus subtilis dibasic endopro
teinase subtilisin A through different mechanisms but failed to inhibi
t the Staphylococcus aureus endoproteinase Glu-C. PI8 inhibited trypsi
n in a purely competitive manner, with an equilibrium inhibition const
ant (K-i) of less than 3.8 nM. The interaction between PI8 and thrombi
n occurred with a second-order association rate constant (k(assoc)) of
1.0 x 10(5) M-1 s(-1) and a K-i of 350 pM. A slow-binding kinetics ap
proach was used to determine the kinetic constants for the interaction
s of PIS with factor Xa and subtilisin A. PI8 inhibited factor Xa via
a two-step mechanism with a k(assoc) of 7.5 x 10(4) M-1 s(-1) and an o
verall K-i of 272 pM. PI8 was a potent inhibitor of subtilisin A via a
single-step mechanism with a k(assoc) of 1.16 x 10(6) M-1 s(-1) and a
n overall K-i of 8.4 pM. The interaction between PI8 and subtilisin A
may be of physiological significance, since subtilisin A is an evoluti
onary precursor to the intracellular mammalian dibasic processing endo
proteinases.